High-Dose SGLT2 Inhibitors Are Better for Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
High-Dose Sodium-Glucose Co-Transporter 2 Inhibitors Are Superior in Type 2 Diabetes: A Meta-Analysis of Randomised Clinical Trials
Diabetes Obes Metab 2021 May 28;[EPub Ahead of Print], FH Shi, H Li, L Shen, JJ Fu, J Ma, ZC Gu, HW LinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.